DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/07fbd3/generic_growth_str) has announced the addition of the "Generic Growth ...
Risk evaluation and mitigation strategy (REMS) programs help ensure that the benefits of certain high-risk medications outweigh their risks. With the routine use of REMS programs, however, concerns ...
Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results